facebook twitter linkedin

This material was prepared by a third party towards Selvita S.A. with its registered office in Kraków (hereunder: “Selvita”). Within the scope which was not authorized by Selvita’s management board, the description of factual circumstances regarding the activities of Selvita, embodied in this material presents merely opinion of the third party, in particular with respect to presented opinions, predictions, appraisals and forecasts of the financial data and future activity of Selvita and its results.

Therefore, Selvita does not warrant consistency of this material with the actual and legal situation. Neither Selvita, members of its corporate bodies, employees nor its consultants shall bear any liability for validity of opinions, predictions, appraisals, forecasts and any other date embodied in this material as well as for consequences of actions of any reader made on a basis of this material, in particular for the investment decisions or any losses resulting from use of this material.

Readers of this material shall make its own assessment, whether opinions or forecasts embodied therein are credible and adequate, in particular taking into account their investment strategy and actual and legal situation. In particular they should consult it with their independent financial and investment advisors. None of the information presented in this material shall constitute investment, legal, accounting or tax advice or a statement that any investment strategy is accurate or adequate, considering the circumstances of the reader.

Furthermore date presented in this material shall not constitute an offer to sell or purchase any financial instruments nor an invite the make such offer. It shall not be also not deemed as a recommendation for investment in any financial instrument nor an advertisement of such instruments.


Analytical reports


25.04.2016 - Fruitful partnership with Merck KGaA - Edison Investment Research 
09.12.2015 - Emerging biotech player - Edison Investment Research 
11.03. 2015 - A record year - Edison Investment Group
18.12.2014 - New money, new listing, new phase - Edison Investment Research
06.11.2014 - Best of both worlds. Selvita initiation of coverage - Edison Investment Research
16.06.2014 - Profile and fund-raising - Edison Investment Research
28.04.2014 - Dual mechanism benefit - Edison Investment Research
19.03.2014 - Seeking the best of two worlds - Edison Investment Research